Tryton Medical, Inc. Announces First Clinical Use Of Its Side-Branch Stent™ To Treat Coronary Bifurcation Lesions

Dateline City: BOSTON BOSTON–(BUSINESS WIRE)–Tryton Medical, Inc. announced today the first clinical use of its Tryton Side-Branch Stent (TM). The initial cases were performed at the Heart Center/Siegburg under the direction of Professor Eberhard Grube, M.D. “These cases demonstrate that a Tryton stent strategy provides a simple and easy way to treat complex bifurcation lesions with beautiful results,” according to …